POPULATION PHARMACOKINETIC STUDY OF GENTAMICIN AND A BAYESIAN APPROACH IN PATIENTS WITH RENAL IMPAIRMENT
暂无分享,去创建一个
A. Domínguez-Gil | M. V. Calvo | J. M. Lanao | A. Berrocal | M. V. Calvo | M. Perez | B. Callet | A. Dominguez‐Gil | B. Callet | M. Perez | J. M. Lanao | A. Berrocal
[1] John A. Nelder,et al. A Simplex Method for Function Minimization , 1965, Comput. J..
[2] J. M. Lanao,et al. Pharmacokinetics of Amikacin (BB-K8) in patients with normal or impaired renal function. , 1979, International journal of clinical pharmacology and biopharmacy.
[3] M. Cobb,et al. Fluorescence immunoassay in the clinical laboratory. , 1982, The American journal of medical technology.
[4] L B Sheiner,et al. Forecasting individual pharmacokinetics , 1979, Clinical pharmacology and therapeutics.
[5] K Yamaoka,et al. A nonlinear multiple regression program, MULTI2 (BAYES), based on Bayesian algorithm for microcomputers. , 1985, Journal of pharmacobio-dynamics.
[6] E. Mellits,et al. Risk factors for nephrotoxicity in patients treated with aminoglycosides. , 1984, Annals of internal medicine.